Bharat Edition

Bharatstox

← All stocks

Max Healthcare Institute Ltd.

NSE: MAXHEALTH · Healthcare

Sector

Healthcare

Size band

Mid cap

Market cap

90,736cr

P/E

131.4

ROE

8.9%

Dividend yield

0.2%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin25.0%
peer 20.0%
Revenue growth16.7%
peer 19.1%
Max Healthcare Institute Ltd.peer median

Peer set

Hospital & Healthcare Services · largest 12 of 23 measured at Q1 FY27 · financials via Screener

What management said

20 statements on record

Earnings call · Q1 FY27 / quarter ended June 30, 2026 · 20 Aug 2026

  • Max Smart capacity commissioning→Remaining 50% beds to be handed over to operations during the current quarter· Current quarter
    “At Max Smart, we have currently operationalized 50% capacity of the 400-bed brownfield tower. The remaining 50% beds are expected to be handed over to operations during the course of the current quarter.”
  • Nanavati Max capacity commissioning→Remaining 50 beds to be operationalized in this quarter· Current quarter
    “At Nanavati Max, remaining 50 beds will also be operationalized in this quarter and work on the Phase 2 expansion has commenced.”
  • Kalinga / Max Bhubaneswar turnaround→Turn around the hospital over the next 12 months· Next 12 months
    “Going forward, our focus is on integrating operations, renovating infrastructure, upgrading technology, and enhancing clinical programs to turn around the hospital over the next 12 months.”
  • Max Vaishali capex and capacity→INR 425 crore capex; add 202 beds; commissioned before FY30· Before FY30
    “To further strengthen our existing Network, the board has approved a capital expenditure of INR 425 crore for a new brownfield tower at Max Vaishali. This will add 202 beds to the hospital's existing capacity of 387 beds. The building plans have been approved and the construction activities have already commenced. The project is expected to be commissioned before FY30.”
  • Max Lucknow capacity→Additional 100 beds commissioned over the next two quarters· Next two quarters
    “100 beds at Max Lucknow: Additional 100 beds in the existing 468-bed facility will be commissioned over the next two quarters.”
  • Sector 56 Gurgaon capacity→500 beds; phased commissioning by end of this year· End of this year
    “500 beds at Sector 56 Gurgaon: We expect to start phased commissioning of this facility by end of this year.”
  • Bhubaneswar renovation / capacity→250 beds; renovation completed within 12 months· Within 12 months
    “250 beds at Bhubaneswar: Renovation of existing facility should be completed within 12 months.”
  • Nagpur capacity→100 beds commissioned by FY28· FY28
    “100 beds at Nagpur: Project work continues to be on track and we expect commissioning by FY28.”
  • Zirakpur, Mohali capacity→400 beds commissioned in FY28· FY28
    “400 beds at Zirakpur, Mohali: Project is on schedule and we expect to commission it in FY28.”
  • Dwarka capacity→260 beds commissioned by FY30· FY30
    “260 beds at Dwarka: which is the next phase because Dwarka hospital is already running full, will be commissioned by FY30.”
  • Pitampura capacity→200 beds commissioned in FY29· FY29
    “200 beds at Pitampura: Project is on track and we expect commissioning in FY29.”
  • Patparganj capacity→400 beds commissioned by end of FY29· End of FY29
    “400 beds at Patparganj: D-wall work has started; we expect commissioning by end of FY29.”
  • Nanavati Phase 2 capacity→271 beds commissioned in FY30· FY30
    “271 beds at Nanavati (Phase 2): Project work has started and will be commissioned in FY30.”
  • Pune capacity→450 beds commissioned by FY30· FY30
    “450 beds at Pune: We have received IOD, project is expected to be commissioned by FY30.”
  • Bhubaneswar ARPOB and occupancy improvement→50% to 80% enhancement in both occupancy and ARPOB· Over the next year or so
    “Yes, because the occupancy is 50% and ARPOB is INR 35,000, we think there is a significant headroom for growth in both of these. You should be able to effectively have a 50% to 80% enhancement in both of these. And in order to do that, we have a current running hospital, so we have a head start. It makes a marginal amount of profit but we have to renovate it, get the technology and get the clinical programs. We intend to do all of this over the next year or so.”
  • Max Smart EBITDA ramp-up timing→Revenue and EBITDA ramp-up by second or third quarter of operations· Second or third quarter of operations
    “No, by the second or third quarter of operations.”
  • Medical college capex and capacity→INR 300 crore spend for a 150-seat medical college
    “Now, we have done some back-of-the-envelope calculations and our take is that for a 150-seat medical college, you need around INR 300 crore of spend.”
  • Medical education ROCE→More than 25% to 30% ROCE· At present
    “We are seeing a more than 25% to 30% ROCE at present and we intend to do this at scale.”
  • Medical college funding→Fund entirely through internal accruals
    “We intend to fund it entirely through internal accruals.”
  • Thane and Shaheed Path project delivery→30 to 36 months for delivery after approvals· After approval, which is another six months from now
    “For both projects after the approval, which is another six months from now, after that they will take about 30 to 36 months for delivery.”

Taken from management commentary on the company’s earnings call and quoted verbatim. These are statements of intent made by the company, not forecasts by Bharatstox, and nothing here records whether they were met.

On air

20 calls · outcomes not tracked

Recorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.

Channel & showAiredStated targetStated stopOutcome
Zee BusinessZee Business · no registration attached9 Oct+15.5%—still open
Zee BusinessZee Business · no registration attached9 Oct+27.1%—still open
Zee BusinessZee Business · no registration attached9 Oct+18.5%—still open
Zee BusinessZee Business · no registration attached9 Oct+18.6%—still open
Zee BusinessZee Business · no registration attached18 Sep+1.5%-2.8%still open
Zee BusinessZee Business · no registration attached18 Sep+1.4%-2.8%still open
CNBC AwaazCNBC Awaax · no registration attached18 Sep+0.7%-2.2%still open
CNBC AwaazCNBC Awaax · no registration attached18 Sep+0.7%-5.0%still open
CNBC AwaazCNBC Awaax · no registration attached18 Sep+0.7%-0.5%still open
Zee BusinessZee Business · no registration attached18 Sep+2.5%-1.8%still open
Zee BusinessZee Business · no registration attached18 Sep+3.3%-1.8%still open
Zee BusinessZee Business · no registration attached18 Sep+2.4%-1.9%still open
Zee BusinessZee Business · no registration attached18 Sep+2.6%-1.7%still open
Zee BusinessZee Business · no registration attached18 Sep+2.6%—still open
Zee BusinessZee Business · no registration attached18 Sep+2.2%-2.1%still open
Zee BusinessZee Business · no registration attached18 Sep+4.1%-2.1%still open
CNBC AwaazCNBC Awaax · no registration attached11 Sep+3.9%-1.3%still open
Zee BusinessZee Business · no registration attached11 Sep+2.0%—still open
Zee BusinessZee Business · no registration attached11 Sep+2.9%—still open
Zee BusinessZee Business · no registration attached11 Sep+3.1%—still open

Shareholding

change across 4 filings
CategorySep 26Jun 26Mar 26Dec 25Change
Promoters23.723.723.723.70.0
Foreign institutions40.541.845.450.6−10.1
Domestic institutions31.030.026.321.2+9.8
Retail & others4.84.64.64.5+0.3

As filed with the exchange for the periods ending Dec 25 to Sep 26.

Filings

latest 25 of 388
  • General Updates16 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Credit Rating9 Oct 2026
    Medium impactCredit RatingFiling PDF ↗
  • Credit Rating9 Oct 2026
    Medium impactCredit RatingFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company29 Sept 2026
    High impactLitigationFiling PDF ↗
  • Trading Window25 Sept 2026
    Medium impactInsider TradingFiling PDF ↗
  • General Updates18 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates14 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Schedule of Investor Conference14 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Schedule of Investor Conference14 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates14 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company11 Sept 2026
    High impactLitigationFiling PDF ↗
  • Copy of Newspaper Publication7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Newspaper publication in Form INC-26 regarding shifting of Registered office7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Update on infusion of funds in Kalinga Hospital Ltd.7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • ESOP/ESOS/ESPS4 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 20224 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Acquisition3 Sept 2026
    High impactM&AFiling PDF ↗
  • Infusion of funds in Kalinga Hospital Ltd.3 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Press Release3 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Press Release - Hon''ble Union Home Minister and Cooperation Minister Shri Amit Shah Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital, Saket3 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201526 Aug 2026
    RoutineGeneralFiling PDF ↗

The 25 most recent of 388 filings we hold for MAXHEALTH, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.